| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/26/2003 | EP1285657A2 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 02/26/2003 | EP1285655A1 Stabilized pharmaceutical compositions containing calcium channel blockers |
| 02/26/2003 | EP1285651A1 Melanin concentrating hormone antagonists |
| 02/26/2003 | EP1284973A2 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 02/26/2003 | EP1284968A1 Method of combating undesired plant growth on cereals |
| 02/26/2003 | EP1284967A1 3-substituted isoquinolin-1-yl derivatives |
| 02/26/2003 | EP1284966A2 Process for the synthesis of amine ethers from secondary amino oxides |
| 02/26/2003 | EP1284734A1 Protein kinase inhibitors |
| 02/26/2003 | EP1284730A1 Aralkyl ester soft drugs |
| 02/26/2003 | EP1150976B1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase |
| 02/26/2003 | EP1131313B1 Enantioselective alkylation of tricyclic compounds |
| 02/26/2003 | EP1112456B1 Tube for lining pipes and channels, and a method and device for the production thereof |
| 02/26/2003 | EP1100797B1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 02/26/2003 | EP1042297B1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 02/26/2003 | EP0971901B1 Phthalazinones |
| 02/26/2003 | EP0938483B1 Muscarinic antagonists |
| 02/26/2003 | EP0934304B1 2-pyrimidineamine derivatives and processes for their preparation |
| 02/26/2003 | EP0832068B1 Stable reagents for the preparation of radiopharmaceuticals |
| 02/26/2003 | EP0798295B1 Novel amidinonaphthyl derivative or salt thereof |
| 02/26/2003 | EP0708763B1 Process for making hiv protease inhibitors |
| 02/26/2003 | CN1399635A Piperazing derivatives as 5-HT1B antagonists |
| 02/26/2003 | CN1399634A Hydroxyalkanoyl aminolactams and related structure as inhibitors of A beta protein production |
| 02/26/2003 | CN1399573A Use of phthalazine derivatives |
| 02/26/2003 | CN1399515A Insecticidal and acaricidal agents |
| 02/26/2003 | CN1102149C 4-haloalkyl-3-heterocycolyl pyridines and 4-haloalkyl-5-heterocyclylpyridines, method for producing same, composition containing same and use thereof |
| 02/26/2003 | CN1102144C Noval pyrimidine derivatives and prepn. processes thereof |
| 02/25/2003 | US6525215 HIV protease inhibitors |
| 02/25/2003 | US6525203 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/25/2003 | US6525202 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |
| 02/25/2003 | US6525069 Such as N-(t-butyl)-N'-(2-((3-(4-fluorophenyl)methyl)piperi -dinyl)methyl)cyclohexyl)urea; prevention of asthma and other allergic diseases |
| 02/25/2003 | US6525059 Substituted pyrazoles as p38 kinase inhibitors |
| 02/25/2003 | US6525054 Cyanoiminoquinoxaline derivatives |
| 02/25/2003 | US6525052 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/25/2003 | US6525046 Aromatic heterocyclic compounds as antiinflammatory agents |
| 02/25/2003 | US6525044 Treatment of neurological disorders related to beta -amyloid production such as Alzheimer's disease and Down's Syndrome. |
| 02/25/2003 | US6525042 Sulfonyl derivatives |
| 02/25/2003 | US6525001 Substituted pyrimidine and pyridine herbicides |
| 02/25/2003 | US6524553 A compound, comprising: a targeting moiety and a chelator, wherein the targeting moiety is bound to the chelator, is a qinolone nonpeptide, and binds to a receptor that is upregulated during angiogenesis |
| 02/20/2003 | WO2003014315A2 Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs |
| 02/20/2003 | WO2003014111A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 02/20/2003 | WO2003014109A1 Process for producing pyridine compound |
| 02/20/2003 | WO2003014108A1 New quinoline carboxylic acid derivatives substituted by 7-(aminomethyl-5-azospiro[2,4]heptane) and their prepartion method |
| 02/20/2003 | WO2003014094A2 Heterocyclic aryl sulphonamides |
| 02/20/2003 | WO2003014092A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 02/20/2003 | WO2003014090A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 02/20/2003 | WO2003014083A1 Spiro compounds |
| 02/20/2003 | WO2003014082A1 Cyclopenta ` b ! indole derivatives as spla2 inhibitors |
| 02/20/2003 | WO2003014075A2 Novel gamma secretase inhibitors |
| 02/20/2003 | WO2003014072A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 02/20/2003 | WO2003013571A1 Peptidomimetics of biologically active metallopeptides |
| 02/20/2003 | WO2003013545A1 Novel benzo-fused heterocycles as endothelin antagonisits |
| 02/20/2003 | WO2003013531A1 Phenyl derivatives as factor xa inhibitors |
| 02/20/2003 | WO2003013528A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
| 02/20/2003 | WO2003013527A1 Sulfonamide derivatives as gamma secretase inhibitors |
| 02/20/2003 | WO2003013526A1 Anticoagulant compounds |
| 02/20/2003 | WO2003013518A1 Alpha-ketoamide derivatives as cathepsin k inhibitors |
| 02/20/2003 | WO2003013510A1 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders |
| 02/20/2003 | WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 02/20/2003 | WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 02/20/2003 | WO2002085291A3 Nociceptin analogs |
| 02/20/2003 | WO2002068399B1 Aryl carbamate derivatives, preparation and use thereof |
| 02/20/2003 | WO2002068387A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/20/2003 | WO2002065979A3 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 02/20/2003 | WO2002064126A3 Method of treating of demyelinating diseases or conditions |
| 02/20/2003 | WO2002050058A8 Crystal forms of 6-[(4-chloro-phenyl) -hydroxy-(-3-methyl- 3h-imidaol-4-yl) -methyl] -4-(3-ethynyl-phenyl) -1-methyl-1h- quinolin-2-one, 2,3- dihydroxybutanedioate salts and method of production |
| 02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
| 02/20/2003 | US20030036656 Method for obtaining derivatives of [ [(pyridil substituted)methyl]thio]benzomidazol |
| 02/20/2003 | US20030036655 2-(substituted-phenyl)amino-imidazoline derivatives |
| 02/20/2003 | US20030036654 Useful as mediators of protein-protein interactions |
| 02/20/2003 | US20030036653 For prophylaxis and therapy of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses- 6 and -7, and Kaposi herpesvirus |
| 02/20/2003 | US20030036557 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 02/20/2003 | US20030036554 Oxidizing the corresponding sulfide without sulfone production to product purer omerprazole, lansoprazole, pantoprazole, rabeprazole, etc. |
| 02/20/2003 | US20030036552 Novel compounds |
| 02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
| 02/20/2003 | CA2462200A1 Peptidomimetics of biologically active metallopeptides |
| 02/20/2003 | CA2457814A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 02/20/2003 | CA2456599A1 Spiro compounds |
| 02/20/2003 | CA2456175A1 Benzoquinone ansamycins |
| 02/20/2003 | CA2455871A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
| 02/20/2003 | CA2455861A1 Sulfonamide derivatives as gamma secretase inhibitors |
| 02/20/2003 | CA2455759A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 02/20/2003 | CA2454417A1 Novel benzo-fused heterocycles as endothelin antagonists |
| 02/19/2003 | EP1284266A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof |
| 02/19/2003 | EP1284140A2 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids |
| 02/19/2003 | EP1283836A2 Neuroprotective and anti-proliferative compounds |
| 02/19/2003 | EP1283835A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 02/19/2003 | EP1283827A2 Caspase inhibitors and uses thereof |
| 02/19/2003 | EP1020179A4 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 02/19/2003 | EP0944603B1 Process for making 2-amino-2-imidazoline, guanidine, and 2-amino-3,4,5,6-tetrahydropyrimidine derivatives |
| 02/19/2003 | EP0920425B1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| 02/19/2003 | EP0917530B1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
| 02/19/2003 | EP0795024B1 Enantioselective preparation of pharmaceutically active sulfoxides by biooxidation |
| 02/19/2003 | EP0774969B1 Hiv protease inhibitor combination |
| 02/19/2003 | EP0690867B1 Taxanes having furyl or thienyl substituted side-chain |
| 02/19/2003 | EP0639189B1 Pyridylpyrimidines, a method of preparing them, and their use in liquid-crystal mixtures |
| 02/19/2003 | CN1398265A 杂环酰胺衍生物 Heterocyclic amide derivatives |
| 02/19/2003 | CN1398264A 吲哚－3－基衍生物 Indol-3-yl derivative |
| 02/19/2003 | CN1398256A Method for producing 5-aryl nicotinaldehydes |